ATE67409T1 - Arzneimittel enthaltend propylenglykol und/oder polyaethylenglykol sowie harnstoff als hauptbestandteile. - Google Patents

Arzneimittel enthaltend propylenglykol und/oder polyaethylenglykol sowie harnstoff als hauptbestandteile.

Info

Publication number
ATE67409T1
ATE67409T1 AT87901161T AT87901161T ATE67409T1 AT E67409 T1 ATE67409 T1 AT E67409T1 AT 87901161 T AT87901161 T AT 87901161T AT 87901161 T AT87901161 T AT 87901161T AT E67409 T1 ATE67409 T1 AT E67409T1
Authority
AT
Austria
Prior art keywords
glycol
urea
propylene glycol
polyaethylene
containing propylene
Prior art date
Application number
AT87901161T
Other languages
English (en)
Inventor
Sven Moberg
Original Assignee
Sven Moberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sven Moberg filed Critical Sven Moberg
Application granted granted Critical
Publication of ATE67409T1 publication Critical patent/ATE67409T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
AT87901161T 1986-02-04 1987-02-04 Arzneimittel enthaltend propylenglykol und/oder polyaethylenglykol sowie harnstoff als hauptbestandteile. ATE67409T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8600501A SE462139B (sv) 1986-02-04 1986-02-04 Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
EP87901161A EP0292495B1 (de) 1986-02-04 1987-02-04 Arzneimittel enthaltend propylenglykol und/oder polyäthylenglykol sowie harnstoff als hauptbestandteile
PCT/SE1987/000053 WO1987004617A1 (en) 1986-02-04 1987-02-04 Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof

Publications (1)

Publication Number Publication Date
ATE67409T1 true ATE67409T1 (de) 1991-10-15

Family

ID=20363358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87901161T ATE67409T1 (de) 1986-02-04 1987-02-04 Arzneimittel enthaltend propylenglykol und/oder polyaethylenglykol sowie harnstoff als hauptbestandteile.

Country Status (9)

Country Link
EP (1) EP0292495B1 (de)
AT (1) ATE67409T1 (de)
AU (1) AU599086B2 (de)
CA (1) CA1330198C (de)
DE (1) DE3773201D1 (de)
DK (1) DK165440C (de)
NO (1) NO174764C (de)
SE (1) SE462139B (de)
WO (1) WO1987004617A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
US5464610A (en) 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
GB9223034D0 (en) * 1992-11-03 1992-12-16 Surtech Int Ltd Method and composition for prevention and/or treatment of dandruff and seborrhoeic dermatitis
DE4322395C1 (de) * 1993-07-01 1994-07-28 Kuehnl Petzoldt Christa Dr Med Duschlotion zur Behandlung und Pflege trockener Haut
US5916545A (en) * 1993-07-28 1999-06-29 Pfizer Inc. Antifungal nail solution
US5391367A (en) * 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution
SE9403541L (sv) * 1994-10-14 1996-04-15 Sven Moberg Antimikrobiell komposition
GB2302808A (en) * 1995-07-04 1997-02-05 Surtech Int Ltd Propylene glycol with low potency corticosteroids for topical treatment of the scalp
US6623724B2 (en) 1996-09-18 2003-09-23 Applied Genetics Incorporated Dermatics Dermatological compositions and methods
AU740783B2 (en) * 1996-09-18 2001-11-15 Applied Genetics Incorporated Dermatics Pharmaceutical compositions and methods
ATE213939T1 (de) * 1997-11-25 2002-03-15 Yamanouchi Europ Bv Verwendung eines gemischs aus einem diol und einer alpha-hydroxysäure zur behandlung hyperkeratotischer hauterkrankungen
ES2272051T3 (es) * 1998-02-13 2007-04-16 Carol J. Buck Uso de composiciones que contienen acido alcanoico para el tratamiento de enfermedades fungicas de las uñas.
AUPQ002999A0 (en) 1999-04-29 1999-05-20 Soltec Research Pty Ltd Non-aqueous shampoo composition
US6835385B2 (en) 2002-06-14 2004-12-28 Carol J. Buck Compositions and methods for softening, thinning and removing hyperkeratotic tissue
US6858215B2 (en) 2002-06-14 2005-02-22 Carol J. Buck Compositions and methods for softening, thinning and removing hyperkeratotic tissue
FR2844197B1 (fr) * 2002-09-05 2006-06-23 Galderma Res & Dev Solution pour application ungueale et peri-ungeale
JP2005538156A (ja) * 2002-09-05 2005-12-15 ガルデルマ・ソシエテ・アノニム 爪塗布用溶液
WO2005115368A1 (en) * 2004-05-31 2005-12-08 Al Tayeb Fayez Hussien Carrier composition for topical formulations
EP1683511A1 (de) * 2005-01-13 2006-07-26 Laboratoires S.V.R. Harnstoof enthaltende Schuppen-regulierende zusammensetzung und ihre dermatologische verwendung
WO2007054833A2 (en) 2005-11-14 2007-05-18 L'oréal Cosmetic use of a hydroxyalkylurea as an agent for treating desquamative conditions of the scalp; cosmetic treatment compositions and processes
WO2008046796A2 (en) * 2006-10-20 2008-04-24 Symrise Gmbh & Co. Kg Use of c10-c14-alkane-1,2-diols in the preparation of a composition for the prophylaxis and/or treatment of dermatophyte infections
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
US20100292333A1 (en) * 2009-05-15 2010-11-18 bioCEPTA Corporation Compositions suitable for the topical treatment of fungal infections of the skin and nails
US20140205639A1 (en) * 2013-01-22 2014-07-24 bioCEPTA Corporation Compositions suitable for the topical treatment of fungal infections of the skin and nails
EP2316438A1 (de) 2009-10-30 2011-05-04 Johnson & Johnson GmbH Band, insbesondere Klebeband zur Behandlung von Hauterkrankungen mit mindestens einem Hyperkeratosehemmer und/oder mindestens einem keratinolytischem Wirkstoff
EP2316436A1 (de) 2009-10-30 2011-05-04 Johnson & Johnson GmbH Band, insbesondere Klebeband zur Behandlung von Hauterkrankungen mit mindestens einem Film, insbesondere einem löslichen Film, mit mindestens einem Enzym
NL2003786C2 (en) * 2009-11-11 2010-07-30 Medner B V COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS.
WO2012110430A1 (en) 2011-02-10 2012-08-23 Moberg Derma Ab Novel composition for topical use on a nail
CN103717212B (zh) * 2011-05-12 2016-06-29 资源管理创新公司 用于治疗过度角化的皮肤的局部制剂
WO2014140507A1 (en) 2013-03-15 2014-09-18 Moberg Pharma Ab Pharmaceutical composition for the treatment of fungal infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395236A (en) * 1961-09-28 1968-07-30 Cleveland J. White Composition comprising oleic acid, polyethylene glycol, and gelating for treating nail infections
SE325667B (de) * 1968-03-06 1970-07-06 Medisan Ab
DE2608221B1 (de) * 1976-02-28 1977-07-21 Beiersdorf Ag Kosmetisches mittel zur glaettung der haut
US4239781A (en) * 1979-05-03 1980-12-16 Roy Edwards Method for treating skin ailments
DE3210138A1 (de) * 1982-03-19 1983-09-22 Röhm Pharma GmbH, 6100 Darmstadt Antimykotische, therapeutische zubereitungen auf creme- und salbenbasis
AU570998B2 (en) 1983-09-07 1988-03-31 Takeda Chemical Industries Ltd. Topical steroid compositions for acne

Also Published As

Publication number Publication date
AU7023987A (en) 1987-08-25
DK165440B (da) 1992-11-30
WO1987004617A1 (en) 1987-08-13
SE8600501D0 (sv) 1986-02-04
EP0292495B1 (de) 1991-09-18
DK519387A (da) 1987-10-02
NO174764B (no) 1994-03-28
NO874150D0 (no) 1987-10-02
SE8600501L (sv) 1987-08-05
AU599086B2 (en) 1990-07-12
NO174764C (no) 1994-07-06
NO874150L (no) 1987-12-02
DK519387D0 (da) 1987-10-02
SE462139B (sv) 1990-05-14
EP0292495A1 (de) 1988-11-30
DE3773201D1 (de) 1991-10-24
DK165440C (da) 1993-04-13
CA1330198C (en) 1994-06-14

Similar Documents

Publication Publication Date Title
ATE67409T1 (de) Arzneimittel enthaltend propylenglykol und/oder polyaethylenglykol sowie harnstoff als hauptbestandteile.
DE59209658D1 (de) Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung
IT1153909B (it) Polimeri reattivi per la cura di affezioni cutanee
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
DE69805983T2 (de) Hustenhemmende, theobromine enthaltende zusammensetzungen
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
GB2114886B (en) Skin treatment compositions containing biotin antagonists
ATE231852T1 (de) Bicyclische aromatische verbindungen
ES2120585T3 (es) Composicion cosmetica o farmaceutica anti radicales libres para aplicacion topica.
FI862609A (fi) Akne motverkande produkt.
DE60132008D1 (de) Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis
SE8500470D0 (sv) Compositions for cosmetic, health- and bodypreserving use
DK137589A (da) Salicylsyreholdigt middel til behandling af hudsygdomme
ATE3552T1 (de) Verfahren zur herstellung von phosphono-hydroxy- essigsaeure und salzen derselben sowie diese enthaltende autivirale mittel.
FR2357250A1 (fr) Composition antimycosique topique contenant un imidazolyl-phenoxyphenyl-pyridinyl-phenylmethane
BE896461A (fr) Composition cosmetique assouplissant la peau, contenant de la thiamorpholinone ou l&#39;un de ses derives
AR017215A1 (es) Composiciones que contienen generadores de oxido nitrico y uso de dichos generadores para la preparacion de un medicamento util para el tratamiento detrastornos de ojo seco
KR880009627A (ko) 모발생장의 치료자극을 위한 조성물
ATE41604T1 (de) Arzneimittel zur oralen verabreichung, bestehend einerseits aus 9-alpha,11-beta-dichlor-16-alphamethyl-21-oxycarbonyldicyclohexyl-methyloxypregna-1,4-diene-3,20-dione als wirksubstanz und andererseits aus einem inerten pharmazeutischen exipiens, das die wirksamkeit des produkts im rektum oder im kolon sich entfalten laesst, sowie die verwendung dieser wirksubstanz zur
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
SU121540A1 (ru) Лекарственна смесь дл лечени себорреи
TH42054A (th) สารผสมดูแลผิวหนัง
PE20001194A1 (es) Composicion cosmetica topica de emulsion de agua en aceite y proceso para la fabricacion de composicion topica cosmetica de emulsion de agua en aceite
KR860000873A (ko) 살균 소독용 의약품 제조방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties